Federal appeals court rules on mail-order access to abortion pill
A federal appeals court has issued a ruling regarding the distribution of mifepristone. This decision may lead to additional legal proceedings. (sources: foxnews, washingtonpost, bbc, abcnews, thehill)
The federal appeals court's ruling blocks the mail distribution of mifepristone, a drug commonly used in medication abortions, and ends pandemic-era regulations. The decision may be appealed to the Supreme Court.
- The appeals court's ruling applies nationwide and restricts access to mifepristone.
- The decision ends rules that allowed for mail-order distribution of the drug during the pandemic.
- Mifepristone is the most common method for medication abortions in the US.
Why it matters
The ruling could impact access to abortion services across the country.
↓ Why this is on ModernAction
4 bills on this issue are moving right now — and the most active one is To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes..
HR679 · 119th Congress
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What HR679 actually does
This story is about a US court order that limits mail delivery of mifepristone and blocks nationwide mail distribution. The bill would reverse FDA changes to the mifepristone REMS and restore prior dispensing rules that restricted remote or mail distribution.
If passed, it would:
- Revert FDA REMS changes for mifepristone • Reinstate clinic-based dispensing requirements.
3 other bills moving on this issue
Take action on any of them individually.
This story is about a US court order that limits mail delivery of the abortion pill and blocks nationwide mail distribution. This bill would amend federal laws tied to mailing restrictions to reduce legal barriers on shipping abortion-related items by mail.
If passed, it would
- Amend federal law to limit use of Comstock-era mailing bans • Reduce legal uncertainty around mailing abortion-related items.
This story is about a federal appeals court limiting mail-order access to mifepristone. This bill would revise federal Comstock-related statutes to clarify and limit use of mailing law as a tool to restrict mailed abortion items.
If passed, it would
- Revise Comstock-era mailing statutes • Provide statutory clarity limiting mailing-based restrictions.
This story is about a federal appeals court limiting mail-order access to mifepristone. The bill would ban telehealth-only chemical abortions by requiring in-person exams, presence during the procedure, and mandated follow-up visits.
If passed, it would
- Require in-person exam and provider presence for medication abortion • Establish criminal penalties for noncompliant providers.
Top coverage · 10 sources